Insmed Earnings
NASDAQ: INSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$-0.37
Insmed earnings summary
Insmed is scheduled to report Sep/2026 earnings on Oct 29, 2026 before the market opens, with analysts expecting EPS of $-0.37. In its most recent report on Aug 6, 2026 (Q2 2026), INSM posted EPS of $-0.06. Revenue for the quarter was $425.5 million.
Across the last 16 reports, INSM shares moved an average of 4.9% (in either direction) in the first trading session after results, rising 12 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
INSM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.06 | — | -5.6% |
| May 7, 2026 | — | $-0.76 | — | +7.7% |
| Feb 19, 2026 | — | $-1.55 | — | -9.4% |
| Oct 30, 2025 | — | $-1.75 | — | +0.1% |
| Aug 7, 2025 | — | $-1.70 | — | +16.7% |
| May 8, 2025 | — | $-1.42 | — | +4.7% |
| Feb 20, 2025 | — | $-1.30 | — | +0.6% |
| Oct 31, 2024 | — | $-1.27 | — | +7.6% |
| Aug 8, 2024 | — | $-1.94 | — | +3.0% |
| May 9, 2024 | — | $-1.06 | — | -4.6% |
| Feb 22, 2024 | — | $-1.28 | — | +2.9% |
| Oct 26, 2023 | — | $-1.11 | — | +4.1% |
| Aug 3, 2023 | — | $-1.78 | — | +2.0% |
| May 4, 2023 | — | $-1.17 | — | -3.5% |
| Feb 23, 2023 | — | $-1.22 | — | +2.6% |
| Oct 27, 2022 | — | $-1.09 | — | +3.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.